Angiogenesis Inhibitors
Links shared publicly online about this topic
Endocrinology Article | Angiogenesis Inhibitors
mdlinx.com — “Early Atheroma-Derived Agonists of Peroxisome Proliferator–Activated Receptor-(gamma) Trigger Intramedial Angiogenesis in a Smooth Muscle Cell–Dependent Manner” View full resource at mdlinx.com
Most Recently Shared on September 3, 2011 at 5:16 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Early Atheroma-Derived Agonists of Peroxisome Proliferator–Activated Receptor-(gamma) Trigger Intramedial ... http://t.co/nMrVcqG #endo
Dr. McDonald on Approved Angiogenesis Inhibitors
onclive.com — “Dr. Donald McDonald from UCSF Comprehensive Cancer Center Explains Approved Angiogenesis Inhibitors” View full resource at onclive.com
Most Recently Shared on September 22, 2011 at 5:00 pm By:
Dr. Donald McDonald from @UCSF Comprehensive Cancer Center Explains Approved Angiogenesis Inhibitors http://ow.ly/6wNSk #OncLiveTV
Dr. McDonald on Resistance to Angiogenesis Inhibitors
onclive.com — “Dr. Donald M. McDonald from the UCSF Cancer Center Discusses Resistance to Angiogenesis Inhibitors” View full resource at onclive.com
Most Recently Shared on September 8, 2011 at 9:02 pm By:
Dr. Donald M. McDonald from the @UCSF Cancer Center Discusses Resistance to Angiogenesis Inhibitors http://t.co/S8hGutt #onclivetv
Gastro Medical News about Angiogenesis Inhibitors
mdlinx.com — “Corticotropin-Releasing Hormone Family of Peptides Regulates Intestinal Angiogenesis” View full resource at mdlinx.com
Most Recently Shared on June 10, 2010 at 1:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Corticotropin-Releasing Hormone Family of Peptides Regulates Intestinal Angiogenesis: Gastroenterology http://bit.ly/cP3w4o #GI
Medical News: SGO: Angiogenesis Inhibitor Scores Split Decision - in Meeting Coverage, SGO from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- An investigational angiogenesis inhibitor produced mixed signals in two small clinical trials involving patients with advanced ovarian cancer.” View full resource at medpagetoday.com
Most Recently Shared on March 22, 2010 at 4:07 pm By:
SGO: Angiogenesis Inhibitor Scores Split Decision (CME/CE) SAN FRANCISCO (MedPage Today) -- An investigational angiog.. http://bit.ly/bXb6a0
Acceleron Pharma Initiates First-in-Human Study Of ACE-041, A Novel Angiogenesis Inhibitor, In Patients With Advanced Cancer
medicalnewstoday.com — “Acceleron pharma, inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, a” View full resource at medicalnewstoday.com
Most Recently Shared on November 6, 2009 at 5:22 am By:
Acceleron Pharma Initiates First-in-Human Study Of ACE-041, A Novel Angiogenesis Inhibitor, In Patients With Ad.. http://bit.ly/1btlyc
Medical News: Angiogenesis Inhibitor Works in Macular Edema - in Ophthalmology, Ophthalmology from MedPage Today
medpagetoday.com — “Patients with macular edema related to retinal vein occlusion had significant improvement in vision when treated with ranibizumab (Lucentis) in each of two dosages, randomized clinical trials showed.” View full resource at medpagetoday.com
Most Recently Shared on October 6, 2009 at 7:46 pm By:
Angiogenesis Inhibitor Works in Macular Edema (CME/CE) http://ow.ly/15Tf1C
Study sheds light on angiogenesis inhibitors, points to limitations, solutions - UCSF News Office
news.ucsf.edu — “A new generation of cancer drugs designed to starve tumors of their blood supply – called “angiogenesis inhibitors” -- succeeds at first, but then promotes more invasive cancer growth -- sometimes with a higher incidence of metastases, according to a new study in animals. The research clarifies similar findings in other animal studies and is consistent with some early evidence from a small number of clinical trials with cancer patients.” View full resource at news.ucsf.edu
Most Recently Shared on March 2, 2009 at 5:48 pm By:
Study sheds light on angiogenesis inhibitors, points to limitations, solutions http://tinyurl.com/ajutcu
Therapeutic Response To The Angiogenesis Inhibitor Sunitinib In Ovarian Clear Cell Cancer « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Therapeutic Response To The Angiogenesis Inhibitor Sunitinib In Ovarian Clear Cell Cancer « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on March 25, 2011 at 10:57 pm By:
Paul Cacciatore Patient Advocate
Therapeutic Response To The Angiogenesis Inhibitor Sunitinib In Ovarian Clear Cell Cancer http://wp.me/pcE2v-1rS
Targeting Of Anti-Angiogenesis Treatment Promised By Spanish Gene Expression Data
medicalnewstoday.com — “Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor d” View full resource at medicalnewstoday.com
Most Recently Shared on May 1, 2010 at 12:05 pm By:
Targeting Of Anti-Angiogenesis Treatment Promised By Spanish Gene Expression Data http://mnt.to/3BZg #lungcancer
Spanish gene expression data promise targeting of anti-angiogenesis treatment
physorg.com — “Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor drugs, a Spanish team reports.” View full resource at physorg.com
Most Recently Shared on April 29, 2010 at 2:52 pm By:
PhysOrg Health News Health News
Spanish gene expression data promise targeting of anti-angiogenesis treatment http://tw.physorg.com/191757142
Targeting tumor angiogenesis with histone deacetyl... [Cancer Lett. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on January 14, 2009 at 6:54 pm By:
prostate_cancer Health Organization
Targeting tumor angiogenesis with histone deacetylase inhibitors. - http://is.gd/fSTb
VEGF is key target for new anti-angiogenesis drugs, Spanish team reports
news-medical.net — “Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor drugs, a Spanish team reports.” View full resource at news-medical.net
Most Recently Shared on May 6, 2010 at 1:14 pm By:
Lung Cancer News: VEGF is key target for new anti-angiogenesis drugs, Spanish team reports: Analyzing the expressi... http://bit.ly/aJn8cO
Cardiology Medical News about Hydroxymethylglutaryl-CoA Reductase Inhibitors
mdlinx.com — “Diverse Effects of Statins on Angiogenesis: New Therapeutic Avenues” View full resource at mdlinx.com
Most Recently Shared on February 10, 2010 at 9:44 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Diverse Effects of Statins on Angiogenesis: New Therapeutic Avenues: Pharmacotherapy http://bit.ly/cJvVTS
Medical News: KCA: VEGF Inhibitor Shows Promise in Refractory RCC - in Meeting Coverage, KCA from MedPage Today
medpagetoday.com — “CHICAGO -- A selective angiogenesis inhibitor achieved stable disease or better response in 95% of patients with treatment-refractory metastatic renal cell cancer in a small phase II study reported he” View full resource at medpagetoday.com
Most Recently Shared on October 1, 2009 at 3:06 pm By:
KCA: VEGF Inhibitor Shows Promise in Refractory RCC (CME/CE) http://bit.ly/MO6ox
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
Advertisement
